Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):679–685. doi: 10.1111/j.1476-5381.1992.tb09038.x

Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.

D N Brindley 1, P Hales 1, A I al-Sieni 1, J C Russell 1
PMCID: PMC1908473  PMID: 1628154

Abstract

1. The effects of D-fenfluramine were studied in the JCR:LA-corpulent rat that is grossly obese, hyperphagic, hyperlipidaemic, hyperinsulinaemic and atherosclerosis-prone. 2. Daily doses of 1, 2.5 and 5 mg kg-1 of D-fenfluramine produced sustained decreases in body weight and food intake over a period of 30 days in 6 month old female rats fed ad libitum. This was accompanied by decreases in the circulating concentrations of glucose, triacylglycerol, free cholesterol and insulin. 3. Food restriction imposed by meal feeding also decreased circulating glucose, triacylglycerols, cholesterol and insulin and diminished the effect of D-fenfluramine on these parameters in male and female rats. 4. Addition of D-fenfluramine to drinking water to give a dose of about 0.25 mg kg-1 daily produced a sustained decrease in body weight and food intake of male and female rats over a nine week period. 5. The results show that the JCR:LA-corpulent rat is very sensitive to the pharmacological effects of D-fenfluramine. These rats should provide an appropriate animal model for determining the mechanisms of action of this anti-obesity agent and whether apparently beneficial changes in metabolism translate into long-term protection against premature atherosclerosis.

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amy R. M., Dolphin P. J., Pederson R. A., Russell J. C. Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent. Atherosclerosis. 1988 Feb;69(2-3):199–209. doi: 10.1016/0021-9150(88)90015-9. [DOI] [PubMed] [Google Scholar]
  2. Bartlett S. M., Gibbons G. F. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 1988 Jan 1;249(1):37–43. doi: 10.1042/bj2490037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baulieu E. E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science. 1989 Sep 22;245(4924):1351–1357. doi: 10.1126/science.2781282. [DOI] [PubMed] [Google Scholar]
  4. Berdanier C. D. Role of glucocorticoids in the regulation of lipogenesis. FASEB J. 1989 Aug;3(10):2179–2183. doi: 10.1096/fasebj.3.10.2666232. [DOI] [PubMed] [Google Scholar]
  5. Bray G. A., York D. A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev. 1979 Jul;59(3):719–809. doi: 10.1152/physrev.1979.59.3.719. [DOI] [PubMed] [Google Scholar]
  6. Brindley D. N., Akester H., Derrick G. P., Irvine C. D., Patmore R. D., Spencer H., Yule-Smith A., Finnerty C., Saxton J., Macdonald I. A. Effects of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerols, glycerol and fatty acid. Biochem Pharmacol. 1988 Feb 15;37(4):695–705. doi: 10.1016/0006-2952(88)90144-x. [DOI] [PubMed] [Google Scholar]
  7. Brindley D. N., Hales P., al-Sieni A. I., Russell J. C. Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex. Biochim Biophys Acta. 1991 Aug 20;1085(1):119–125. doi: 10.1016/0005-2760(91)90239-e. [DOI] [PubMed] [Google Scholar]
  8. Brindley D. N., Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin Sci (Lond) 1989 Nov;77(5):453–461. doi: 10.1042/cs0770453. [DOI] [PubMed] [Google Scholar]
  9. Brindley D. N., Saxton J., Shahidullah H., Armstrong M. Possible relationships between changes in body weight set-point and stress metabolism after treating rats chronically with D-fenfluramine. Effects of feeding rats acutely with fructose on the metabolism of corticosterone, glucose, fatty acids, glycerol and triacylglycerol. Biochem Pharmacol. 1985 Apr 15;34(8):1265–1271. doi: 10.1016/0006-2952(85)90504-0. [DOI] [PubMed] [Google Scholar]
  10. Dallman M. F., Darlington D. N., Suemaru S., Cascio C. S., Levin N. Corticosteroids in homeostasis. Acta Physiol Scand Suppl. 1989;583:27–34. [PubMed] [Google Scholar]
  11. Devenport L., Knehans A., Sundstrom A., Thomas T. Corticosterone's dual metabolic actions. Life Sci. 1989;45(15):1389–1396. doi: 10.1016/0024-3205(89)90026-x. [DOI] [PubMed] [Google Scholar]
  12. Dolphin P. J., Amy R. M., Russell J. C. Effect of age on serum lipids and lipoproteins of male and female JCR:LA-corpulent rats. Biochim Biophys Acta. 1990 Jan 16;1042(1):99–106. doi: 10.1016/0005-2760(90)90062-3. [DOI] [PubMed] [Google Scholar]
  13. Dolphin P. J., Stewart B., Amy R. M., Russell J. C. Serum lipids and lipoproteins in the atherosclerosis prone LA/N corpulent rat. Biochim Biophys Acta. 1987 Jun 2;919(2):140–148. doi: 10.1016/0005-2760(87)90200-1. [DOI] [PubMed] [Google Scholar]
  14. Fuller R. W., Snoddy H. D., Clemens J. A. Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats. Pharmacol Res Commun. 1981 Mar;13(3):275–280. doi: 10.1016/s0031-6989(81)80108-7. [DOI] [PubMed] [Google Scholar]
  15. Langley S. C., York D. A. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am J Physiol. 1990 Sep;259(3 Pt 2):R539–R544. doi: 10.1152/ajpregu.1990.259.3.R539. [DOI] [PubMed] [Google Scholar]
  16. Levitsky D. A., Strupp B. J., Lupoli J. Tolerance to anorectic drugs: pharmacological or artifactual. Pharmacol Biochem Behav. 1981 May;14(5):661–667. doi: 10.1016/0091-3057(81)90128-3. [DOI] [PubMed] [Google Scholar]
  17. Mangiapane E. H., Brindley D. N. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J. 1986 Jan 1;233(1):151–160. doi: 10.1042/bj2330151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Martin-Sanz P., Vance J. E., Brindley D. N. Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone. Biochem J. 1990 Nov 1;271(3):575–583. doi: 10.1042/bj2710575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rowland N. E., Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol. 1986;27(1):13–62. doi: 10.1016/0301-0082(86)90011-0. [DOI] [PubMed] [Google Scholar]
  20. Russell J. C., Ahuja S. K., Manickavel V., Rajotte R. V., Amy R. M. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis. 1987 Nov-Dec;7(6):620–626. doi: 10.1161/01.atv.7.6.620. [DOI] [PubMed] [Google Scholar]
  21. Russell J. C., Amy R. M. Early atherosclerotic lesions in a susceptible rat model. The LA/N-corpulent rat. Atherosclerosis. 1986 May;60(2):119–129. doi: 10.1016/0021-9150(86)90004-3. [DOI] [PubMed] [Google Scholar]
  22. Russell J. C., Amy R. M., Manickavel V., Dolphin P. J. Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat. Arteriosclerosis. 1989 Jan-Feb;9(1):122–128. doi: 10.1161/01.atv.9.1.122. [DOI] [PubMed] [Google Scholar]
  23. Russell J. C., Amy R. M., Manickavel V., Dolphin P. J., Epling W. F., Pierce D., Boer D. P. Prevention of myocardial disease in JCR:LA-corpulent rats by running. J Appl Physiol (1985) 1989 Apr;66(4):1649–1655. doi: 10.1152/jappl.1989.66.4.1649. [DOI] [PubMed] [Google Scholar]
  24. Russell J. C., Amy R. M. Myocardial and vascular lesions in the LA/N-corpulent rat. Can J Physiol Pharmacol. 1986 Oct;64(10):1272–1280. doi: 10.1139/y86-215. [DOI] [PubMed] [Google Scholar]
  25. Russell J. C., Dolphin P. J., Hameed M., Stewart B., Koeslag D. G., Rose-Kahn G., Bar-Tana J. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Arterioscler Thromb. 1991 May-Jun;11(3):602–609. doi: 10.1161/01.atv.11.3.602. [DOI] [PubMed] [Google Scholar]
  26. Russell J. C., Koeslag D. G., Amy R. M., Dolphin P. J. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis. 1989 Nov-Dec;9(6):869–876. doi: 10.1161/01.atv.9.6.869. [DOI] [PubMed] [Google Scholar]
  27. Russell J. C., Koeslag D. G., Dolphin P. J., Amy R. M. Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine. Arteriosclerosis. 1990 Jul-Aug;10(4):658–664. doi: 10.1161/01.atv.10.4.658. [DOI] [PubMed] [Google Scholar]
  28. Russell J. C., Koeslag D. G., Manickavel V., Amy R. M., Dolphin P. J. Effects of advancing age and severe food restriction on pathological processes in the insulin resistant JCR:LA-corpulent rat. Diabetes Res. 1990 Oct;15(2):53–62. [PubMed] [Google Scholar]
  29. Schettini G., Quattrone A., Gianfranco D. R., Preziosi P. Effect of selective degeneration of brain serotonin-containing neurons on plasma corticosterone levels: studies with d-fenfluramine. Pharmacol Res Commun. 1979 Jun;11(6):545–553. doi: 10.1016/s0031-6989(79)80027-2. [DOI] [PubMed] [Google Scholar]
  30. Stunkard A. J. Anorectic agents lower a body weight set point. Life Sci. 1982 Jun 14;30(24):2043–2055. doi: 10.1016/0024-3205(82)90445-3. [DOI] [PubMed] [Google Scholar]
  31. Vance J. E., Russell J. C. Hypersecretion of VLDL, but not HDL, by hepatocytes from the JCR:LA-corpulent rat. J Lipid Res. 1990 Aug;31(8):1491–1501. [PubMed] [Google Scholar]
  32. al-Sieni A. I., Plested C. P., Rolland Y., Brindley D. N. Decreased incorporation of glucose into lipids and increased lactate production by adipose tissue after long-term treatment of rats with D-fenfluramine. Biochem Pharmacol. 1989 Nov 1;38(21):3661–3667. doi: 10.1016/0006-2952(89)90569-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES